Inherited retinal diseases target of potential treatments

Article

Forty potential new treatments for inherited retinal diseases are under development, according to a review by the National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with charitable organization Fight for Sight.

Forty potential new treatments for inherited retinal diseases are under development, according to a review by the National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with charitable organization Fight for Sight.

The promising technologies - identified through consultations and focus groups with patients, families, caregivers and eye health professionals - include nine gene therapy approaches, ten medical devices, five drugs and five regenerative and cell development approaches. Eleven additional technologies are at a very early stage of development. Most of the technologies identified are in clinical trials or are expected to be soon.

"With further support and funding, these therapies and technologies could have a major impact on people's lives," says Michele Acton, chief executive of Fight for Sight.

For more information on the review visit the NIHR HSC website here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.